Coeptis Therapeutics Stock Price Prediction
| COEP Stock | USD 10.70 0.02 0.19% |
Momentum 48
Impartial
Oversold | Overbought |
Wall Street Target Price 3 | Quarterly Revenue Growth 15.637 |
Using Coeptis Therapeutics hype-based prediction, you can estimate the value of Coeptis Therapeutics from the perspective of Coeptis Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Coeptis Therapeutics Hype to Price Pattern
Investor biases related to Coeptis Therapeutics' public news can be used to forecast risks associated with an investment in Coeptis. The trend in average sentiment can be used to explain how an investor holding Coeptis can time the market purely based on public headlines and social activities around Coeptis Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Coeptis Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Coeptis Therapeutics.
The fear of missing out, i.e., FOMO, can cause potential investors in Coeptis Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Coeptis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Coeptis Therapeutics after-hype prediction price | USD 10.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Coeptis Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Coeptis Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Coeptis Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Coeptis Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Coeptis Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Coeptis Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Coeptis Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Coeptis Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Coeptis Therapeutics' historical news coverage. Coeptis Therapeutics' after-hype downside and upside margins for the prediction period are 3.32 and 18.14, respectively. We have considered Coeptis Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Coeptis Therapeutics is risky at this time. Analysis and calculation of next after-hype price of Coeptis Therapeutics is based on 3 months time horizon.
Coeptis Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Coeptis Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Coeptis Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Coeptis Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 7.41 | 0.03 | 0.00 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
10.70 | 10.73 | 0.28 |
|
Coeptis Therapeutics Hype Timeline
Coeptis Therapeutics is currently traded for 10.70. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of 0.0. Coeptis is forecasted to increase in value after the next headline, with the price projected to jump to 10.73 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 0.28%, whereas the daily expected return is currently at 0.06%. The volatility of related hype on Coeptis Therapeutics is about 10220.69%, with the expected price after the next announcement by competition of 10.70. Net Loss for the year was (10.88 M) with profit before overhead, payroll, taxes, and interest of 17.72 K. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Coeptis Therapeutics Basic Forecasting Models to cross-verify your projections.Coeptis Therapeutics Related Hype Analysis
Having access to credible news sources related to Coeptis Therapeutics' direct competition is more important than ever and may enhance your ability to predict Coeptis Therapeutics' future price movements. Getting to know how Coeptis Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Coeptis Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LSB | LakeShore Biopharma Co, | 0.30 | 4 per month | 0.00 | (0.05) | 9.26 | (8.00) | 54.58 | |
| SPRC | Scisparc | 0.11 | 10 per month | 4.88 | 0.09 | 8.94 | (6.22) | 60.89 | |
| CVKD | Cadrenal Therapeutics, Common | 0.23 | 6 per month | 0.00 | (0.15) | 7.07 | (7.54) | 24.31 | |
| HOTH | Hoth Therapeutics | 0.12 | 7 per month | 4.82 | 0.1 | 10.00 | (8.45) | 87.22 | |
| CDIO | Cardio Diagnostics Holdings | (0.22) | 7 per month | 0.00 | (0.11) | 13.41 | (12.74) | 60.92 | |
| ZVSA | ZyVersa Therapeutics | 0.03 | 5 per month | 0.00 | (0.21) | 9.38 | (17.95) | 67.27 | |
| ICU | LMF Acquisition Opportunities | 0.03 | 10 per month | 11.03 | (0.01) | 13.95 | (11.01) | 71.01 | |
| DRMA | Dermata Therapeutics | (0.02) | 6 per month | 3.31 | (0.02) | 8.47 | (6.35) | 22.00 |
Coeptis Therapeutics Additional Predictive Modules
Most predictive techniques to examine Coeptis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Coeptis using various technical indicators. When you analyze Coeptis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Coeptis Therapeutics Predictive Indicators
The successful prediction of Coeptis Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Coeptis Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Coeptis Therapeutics based on analysis of Coeptis Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Coeptis Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Coeptis Therapeutics's related companies. | 2024 | 2025 (projected) | Interest Debt Per Share | 0.73 | 0.69 | Revenue Per Share | 0.003302 | 0.00207 |
Story Coverage note for Coeptis Therapeutics
The number of cover stories for Coeptis Therapeutics depends on current market conditions and Coeptis Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Coeptis Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Coeptis Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Coeptis Therapeutics Short Properties
Coeptis Therapeutics' future price predictability will typically decrease when Coeptis Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Coeptis Therapeutics often depends not only on the future outlook of the potential Coeptis Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Coeptis Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 M | |
| Cash And Short Term Investments | 532.9 K |
Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.